The global healthcare nanotechnology market is expected to reach USD
196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by
Grand View Research, Inc. Increasing susceptibility of patients towards chronic
diseases such as cardiovascular, neurological, oncology and respiratory
diseases coupled with increasing R&D spending opening new application
avenues is expected to drive market growth over the next six years. Other
drivers of this market include increasing government and private sector R&D
aid and new players entering the market to bridge the gap between supply and
demand.
Clinical oncology nanotechnology applications dominated the overall
market in 2013, accounting for 35% of total market revenue. Higher efficacy of
nanomaterials and the ability of engineered nanoparticles to cross through the
blood brain barrier provides platform for groundbreaking innovations through
R&D in the field of cancer therapy and serves this market as a high impact
rendering driver.
In depth research report
on Healthcare Nanotechnology (Nanomedicine) Market
Further key findings from
the study suggest:
·
North America was the largest regional market in 2013, accounting for
over 38% of global revenue on account of the extensive investments in research
and development of innovative cancer therapies.
·
Asia Pacific owing to its improving healthcare infrastructure and
healthcare R&D spending is expected to grow at the highest CAGR of over
14.0% from 2014 to 2020. Moreover, emerging markets such as China and India
hold a large amount of untapped opportunities and are therefore expected to
fuel future market growth.
·
Cardiovascular applications are expected to be the fastest growing
segment for this market, owing to the growing global prevalence of
cardiovascular diseases.
Grand View Research has segmented the global healthcare nanotechnology
market on the basis of fields of application and region:
Healthcare Nanotechnology
Application Outlook
·
Drug delivery Systems
·
Molecular Diagnostics
·
Clinical Oncology
·
Clinical Neurology
·
Clinical Cardiology
·
Anti-inflammatory and Anti-infective applications
Healthcare Nanotechnology
Regional Outlook
·
North America
·
Europe
·
Asia Pacific
·
RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
No comments:
Post a Comment